Radiation enhances regulatory T cell representation

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages 1128-1135

  Kachikwu, Evelyn L ^a   Iwamoto, Keisuke S ^a   Liao, Yu Pei ^a   Demarco, John J ^a   Agazaryan, Nzhde ^a   Economou, James S ^a   McBride, William H ^a   Schaue, Dörthe ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti CD25 therapy; Radiation therapy; T regulatory cells; Transgenic adenocarcinoma of mouse prostate

Indexed keywords

ANTI-CD25 THERAPY; ANTI-TUMOR IMMUNE; CYTOTOXIC; FUNCTIONAL ACTIVITIES; HOMEOSTATIC MECHANISM; IMMUNE MODULATION; IMMUNE ORGANS; LARGE PARTS; MICROMETASTATIC DISEASE; PROSTATE CANCERS; PROSTATE TUMOR; RADIATION EXPOSURE; RADIATION RESISTANT; RADIATION-INDUCED; T CELLS; T REGULATORY CELLS; TRANSGENICS; TREG CELLS; TUMOR REGRESSION; WHOLE-BODY;

CELL CULTURE; CELL PROLIFERATION; CELLS; DISEASE CONTROL; DISEASES; MAMMALS; RADIATION; TUMORS;

RADIOTHERAPY;

TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CD4+ CD25+ T LYMPHOCYTE; CELL FATE; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR REGRESSION; WHOLE BODY RADIATION;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD24; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HINDLIMB; IMMUNOTHERAPY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPH NODES; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; SCATTERING, RADIATION; SPLEEN; T-LYMPHOCYTES, REGULATORY; WHOLE-BODY IRRADIATION;

EID: 80255141797     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.034     Document Type: Article

References (32)

1. Y.P. Liao, C.C. Wang, and L.H. Butterfield Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells J Immunol 173 2004 2462 2469 (Pubitemid 39063103)
2. C.H. Tsai, J.H. Hong, and K.F. Hsieh Tetracycline-regulated intratumoral expression of interleukin-3 enhances the efficacy of radiation therapy for murine prostate cancer Cancer Gene Ther 13 2006 1082 1092
3. D. Schaue, B. Comin-Anduix, and A. Ribas T-cell responses to survivin in cancer patients undergoing radiation therapy Clin Cancer Res 14 2008 4883 4890
4. J. Dannull, Z. Su, and D. Rizzieri Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells J Clin Invest 115 2005 3623 3633 (Pubitemid 43121851)
5. U.K. Liyanage, T.T. Moore, and H.G. Joo Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2002 2756 2761 (Pubitemid 34921025)
6. T.J. Curiel, G. Coukos, and L. Zou Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942 949 (Pubitemid 39273735)
7. A.M. Miller, K. Lundberg, and V. Ozenci CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients J Immunol 177 2006 7398 7405 (Pubitemid 44715110)
8. E.M. Shevach CD4+ CD25+ suppressor T cells: More questions than answers Nat Rev Immunol 2 2002 389 400 (Pubitemid 37328746)
9. B.H. Nelson IL-2, regulatory T cells, and tolerance J Immunol 172 2004 3983 3988 (Pubitemid 38375208)
10. J.A. Bluestone, and A.K. Abbas Natural versus adaptive regulatory T cells Nat Rev Immunol 3 2003 253 257 (Pubitemid 37323210)
11. M.L. Chen, M.J. Pittet, and L. Gorelik Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo Proc Natl Acad Sci U S A 102 2005 419 424 (Pubitemid 40116782)
12. N.A. Louis, A.M. Robinson, and C.F. MacManus Control of IFN-alphaA by CD73: implications for mucosal inflammation J Immunol 180 2008 4246 4255
13. M. Mandapathil, B. Hilldorfer, and M.J. Szczepanski Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells J Biol Chem 285 2010 7176 7186
14. A. Ohta, M. Madasu, and R. Kini A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments J Immunol 183 2009 5487 5493
15. M. Sitkovsky, D. Lukashev, and S. Deaglio Adenosine A2A receptor antagonists: Blockade of adenosinergic effects and T regulatory cells Br J Pharmacol 153 Suppl. 1 2008 S457 S464
16. M.V. Sitkovsky, J. Kjaergaard, and D. Lukashev Hypoxia-adenosinergic immunosuppression: Tumor protection by T regulatory cells and cancerous tissue hypoxia Clin Cancer Res 14 2008 5947 5952
17. S. Sheth, W. Bleibel, and C. Thukral Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis Purinergic Signal 5 2009 321 326
18. S. Sakaguchi Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562 (Pubitemid 38680433)
19. J.D. Fontenot, and A.Y. Rudensky A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3 Nat Immunol 6 2005 331 337 (Pubitemid 41716769)
20. E. Jaeckel, H. von Boehmer, and M.P. Manns Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes Diabetes 54 2005 306 310
21. C. Mottet, H.H. Uhlig, and F. Powrie Cutting edge: Cure of colitis by CD4+CD25+ regulatory T cells J Immunol 170 2003 3939 3943 (Pubitemid 36428153)
22. D. Haribhai, W. Lin, and L.M. Relland Regulatory T cells dynamically control the primary immune response to foreign antigen J Immunol 178 2007 2961 2972 (Pubitemid 46333175)
23. A. Van der Meeren, P. Monti, and M. Vandamme Abdominal radiation exposure elicits inflammatory responses and abscopal effects in the lungs of mice Radiat Res 163 2005 144 152 (Pubitemid 40170763)
24. M.Z. Dewan, A.E. Galloway, and N. Kawashima Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody Clin Cancer Res 15 2009 5379 5388
25. Y. Qu, S. Jin, and A. Zhang Gamma-ray resistance of regulatory CD4+CD25+Foxp3+ T cells in mice Radiat Res 173 2010 148 157
26. P.W. Shueng, S.C. Lin, and H.T. Chang Toxicity risk of non-target organs at risk receiving low-dose radiation: Case report Radiat Oncol 4 2009 71
27. C. Belka, H. Ottinger, and E. Kreuzfelder Impact of localized radiotherapy on blood immune cells counts and function in humans Radiother Oncol 50 1999 199 204 (Pubitemid 29155546)
28. M. Martin, J. Lefaix, and S. Delanian TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47 2000 277 290 (Pubitemid 30236366)
29. W. Chen, W. Jin, and N. Hardegen Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 2003 1875 1886 (Pubitemid 38032120)
30. M. Mandapathil, M.J. Szczepanski, and M. Szajnik Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer Clin Cancer Res 15 2009 6348 6357
31. R.J. North Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells J Exp Med 164 1986 1652 1666 (Pubitemid 17184195)
32. C. Kudo-Saito, J. Schlom, and K. Camphausen The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors Clin Cancer Res 11 2005 4533 4544 (Pubitemid 40825644)